Recent Advances in Understanding Glaucoma Pathophysiology
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 259
Special Issue Editors
Interests: glaucoma; cataract; cornea and conjunctiva diseases; corneal transplantation; dry eye syndrome; contact lens
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Glaucoma is an irreversible blinding disease that involves distinct optic nerve degeneration and retinal ganglion cell (RGC) death associated with corresponding visual field defects. Intraocular pressure and other non-IOP factors, such as vascular factors, have been addressed as possible causes for glaucomatous damage development and progression. Other possible mechanisms have been suggested, including autophagy, oxidative stress, mitochondrial dysfunction and neuroinflammation. However, there are still many mysteries to unravel to understand the complex pathophysiology of the disease’s development and progression. The aim of the current Special Issue is to explore the recent advances in the field to better understand the complex mechanisms responsible for glaucomatous optic nerve damage and RGC death. We invite the submission of innovative research papers and review articles that discuss glaucoma pathophysiology.
Dr. Si Hyung Lee
Dr. Wungrak Choi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- glaucoma
- optic nerve
- retinal ganglion cells
- intraocular pressure
- pathophysiology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.